During the past 12 months, TransMedics Group's average Revenue per Share Growth Rate was 131.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 92.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 49.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of TransMedics Group was 92.70% per year. The lowest was 17.50% per year. And the median was 25.00% per year.
Competitive Comparison of TransMedics Group's 3-Year Revenue Growth Rate
For the Medical Devices subindustry, TransMedics Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where TransMedics Group's 3-Year Revenue Growth Rate falls into.
TransMedics Group 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
TransMedics Group (NAS:TMDX) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
TransMedics Group 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of TransMedics Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
TransMedics Group (TransMedics Group) Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMDX has been successfully added to your